We are excited to welcome Dr Shehzahdi Shebbrin Moonshi to Ta group. Originally, from Singapore, she has completed her undergrad (Griffith University) and PhD (University of Queensland, UQ) in Brisbane under the supervision of Professor Andrew Whittaker. She completed her PhD at UQ’s AIBN where her research was focused on the in vivo tracking of human placenta derived- mesenchymal stem cells (MSCs) using 19F MRI and optical imaging. Shebbrin worked as a cancer biologist in the Tumour Biology & Targeting Group in Children’s Cancer Institute Australia with Dr Angelica Merlot under Professor Maria Kavallaris. The project that she led is centred at developing and applications of novel therapeutics, specifically thiosemicarbazone based nanoparticles, for the treatment of aggressive forms of cancer with fewer side effects. Shebbrin also had five years of experience as a Senior Research Officer in Singapore Bioimaging Consortium, A*star, in a Translational Molecular Imaging Group and Translational Imaging Industrial Laboratory working with PET and MRI imaging in various disease models.
